The global estrone market is anticipated to grow at a CAGR of 6.2% during the forecast period (2022-2028). Estrone was marketed as oestrogen in intramuscular and vaginal formulations for the treatment of low oestrogen symptoms such as hot flashes and vaginal atrophy in postmenopausal or ovariectomized women. Estrone has also been used to treat prostate […]
